Isoniasied%D8%A2%D9%8A%D8%B2%D9%88%D9%86%D9%8A%D8%A7%D8%B2%D9%8A%D8%AF%D8%A7%DB%8C%D8%B2%D9%88%D9%86%DB%8C%D8%A7%D8%B2%DB%8C%D8%AFCategory:IsoniazidIsoniazidIsoniasidIsoniazidIsoniazid%CE%99%CF%83%CE%BF%CE%BD%CE%B9%CE%B1%CE%B6%CE%AF%CE%B4%CE%B7IsoniazidIsoniacida%D8%A7%DB%8C%D8%B2%D9%88%D9%86%DB%8C%D8%A7%D8%B2%DB%8C%D8%AFIsoniatsidiIsoniazide%D7%90%D7%99%D7%96%D7%95%D7%A0%D7%99%D7%90%D7%96%D7%99%D7%93%D4%BB%D5%A6%D5%B8%D5%B6%D5%AB%D5%A1%D5%A6%D5%AB%D5%A4IsoniazidIsoniazide%E3%82%A4%E3%82%BD%E3%83%8B%E3%82%A2%E3%82%B8%E3%83%89%E0%B2%90%E0%B2%B8%E0%B3%8A%E0%B2%A8%E0%B2%BF%E0%B2%AF%E0%B2%BE%E0%B2%9C%E0%B2%BF%E0%B2%A1%E0%B3%8D%EC%9D%B4%EC%86%8C%EB%8B%88%EC%95%84%EC%A7%80%EB%93%9CIzoniazidas%E0%B4%90%E0%B4%B8%E0%B5%8B%E0%B4%A8%E0%B4%BF%E0%B4%AF%E0%B4%BE%E0%B4%B8%E0%B4%BF%E0%B4%A1%E0%B5%8DIsoniazideIsoniazidIsoniazid%E0%AC%86%E0%AC%87%E0%AC%B8%E0%AD%8B%E0%AC%A8%E0%AC%BF%E0%AC%86%E0%AC%9C%E0%AC%BF%E0%AC%A1IzoniazydIsoniazidaIzoniazid%C4%83%D0%98%D0%B7%D0%BE%D0%BD%D0%B8%D0%B0%D0%B7%D0%B8%D0%B4IzoniazidIzoniazidIzoniazidIsoniazid%C4%B0zoniazid%D0%86%D0%B7%D0%BE%D0%BD%D1%96%D0%B0%D0%B7%D0%B8%D0%B4IsoniazidQ423169%E5%BC%82%E7%83%9F%E8%82%BC
about
sameAs
Measurement of Anti-TB Drugs in Lung Tissue From Patients Having Surgery to Treat TuberculosisEarly Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)Anti-tuberculosis (TB) Drug Levels and Correlation With Drug Induced HepatotoxicityHigh-Dose Isoniazid Adjuvant Therapy for Multidrug Resistant TuberculosisControlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary TuberculosisSimultaneous Versus Sequential Antiretroviral Therapy (ARV) Therapy and Mycobacterium Tuberculosis (MTB) TreatmentEvaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant WomenBioequivalence Study Comparing Rifampicin In A Fixed-Dose Combination (Rifampicin+Isoniazid, Myrin© 2) And The Reference Drug (Rifampicin, Rimactane®)A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism StatusImpact of Weekly Administration of Rifapentine and Isoniazid on Steady State Pharmacokinetics of Tenofovir Alafenamide in Healthy Volunteers (YODA)Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis PatientsPilot Clinical Trial of PRS TB Regimen I - Phase IIEvaluation of Diabetes Control and Effect on Transmission and Development of TuberculosisSimplified Isoniazid Preventive Therapy Strategy to Reduce TB BurdenEfficacy, Security, Adherence, Tolerability and Cost Effectiveness of Latent TB Treatment in Patients With TB/DM2 (TBL)Impact of Once-Weekly Rifapentine and Isoniazid on the Steady State Pharmacokinetics of Dolutegravir and Darunavir Boosted With Cobicistat in Healthy VolunteersEvaluating the Pharmacokinetics, Tolerability, and Safety of Once-Weekly Rifapentine and Isoniazid in HIV-1-Infected and HIV-1-Uninfected Pregnant and Postpartum Women With Latent Tuberculosis InfectionShort Course Rifapentine and Isoniazid for the Preventive Treatment of Tuberculosis(SCRIPT-TB)A Clinical Trial of the Safety, Pharmacokinetics and Hematologic Effects of Imatinib on Myelopoiesis in Adults When Given With and Without Isoniazid and RifabutinAdequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) TabletOptimizing Antituberculosis Therapy in Adults With Tuberculous MeningitisTuberculosis Preventive Therapy Among Latent Tuberculosis Infection in HIV-infected IndividualsVideo Based Directly Observed Therapy for Latent TBTuberculosis Clinical Trials Consortium Study 35Safety Tolerability DDI Short Course Treatment of LTBI Infection With High-dose Rifapentine Isoniazid in HIV+ PatientsOptions for Delivering Isoniazid-Rifapentine (3HP) for TB Prevention (3HP Options Implementation Trial)Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected IndividualsNovel Triple-dose Tuberculosis Retreatment RegimenClofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study
P4844
P769
Clinical and experimental studies of distal axonopathy -- a frequent form of brain and nerve damage produced by environmental chemical hazardsClinical and experimental studies of distal axonopathy -- a frequent form of brain and nerve damage produced by environmental chemical hazardsLymphocyte transformation studies in drug hypersensitivityIsoniazid: metabolic aspects and toxicological correlates.Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial.Isonicotinic acid hydrazide: an anti-tuberculosis drug inhibits malarial transmission in the mosquito gut.Exposure of Infants to Isoniazid via Breast Milk After Maternal Drug Intake of Recommended Doses Is Clinically Insignificant Irrespective of Metaboliser Status. A Physiologically-Based Pharmacokinetic (PBPK) Modelling Approach to Estimate Drug ExposuThe treatment of pulmonary tuberculosis amongst Africans in Bulawayo. III. Criteria of selection for out-patient statusStudy of correlation between the NAT2 phenotype and genotype status among Greenlandic Inuit[METABOLISM OF ISONICOTINIC ACID HYDRAZIDE. IV. IDENTIFICATION, SEPARATION AND DETERMINATION, USING PAPER CHROMATOGRAPHY, OF VARIOUS METABOLIC PRODUCTS OF ISONIAZID AND VARIOUS PYRIDOXINE DERIVATIVES PRESENT IN THE URINE.]Para-aminosalicylic acid increases the susceptibility to isoniazid in clinical isolates ofDesign, Synthesis, and Evaluation of Monoamine Oxidase A Inhibitors⁻Indocyanine Dyes Conjugates as Targeted Antitumor AgentsMultidrug-resistant tuberculosis outbreak associated with poor treatment adherence and delayed treatment: Arua District, Uganda, 2013-2017Window Period Prophylaxis for Children Exposed to Tuberculosis, Houston, Texas, USA, 2007-2017Response to Isoniazid-Resistant Tuberculosis in Homeless Shelters, Georgia, USA, 2015-2017Cross-Border Movement of Highly Drug-Resistant Mycobacterium tuberculosis from Papua New Guinea to Australia through Torres Strait Protected Zone, 2010-2015Rapid and accurate detection of rifampin and isoniazid-resistant Mycobacterium tuberculosis using an oligonucleotide arrayValidation of Novel Mycobacterium tuberculosis Isoniazid Resistance Mutations Not Detectable by Common Molecular TestsClinical implications of discrepant results between genotypic MTBDR and phenotypic Löwenstein-Jensen method for isoniazid or rifampicin drug susceptibility tests in tuberculosis patientsOptimization of dosing regimens of isoniazid and rifampicin in children with tuberculosis in India
P921
Q61865065-D31609E0-6493-4C0A-BA81-5CF925ED9043Q61917550-9C2B2459-3162-4DF4-B6D6-5E82C7015CD8Q61917577-B823730E-2133-41D4-9868-5F6B9B32AFECQ61966022-C7FB799E-B69D-4B42-8DCC-D7BD93C16D85Q61978963-7DAB5825-065B-4085-94BC-E4895B181897Q61981168-F2A3B60F-CD31-424D-8BE3-9CC1BF546D35Q63063167-4383D5E4-0B17-402D-A212-28D7BCFCBEC0Q63319796-27548B56-5342-4A10-B740-0AED27A98991Q63339148-CD8AEBCD-A7DF-4EAF-9764-EBBB99239AC6Q63393584-7350AA54-3CFA-431F-BC8E-F2E791A460FFQ63397746-5A059140-70C7-45B5-9711-F49ADFDFA2A6Q63397789-6BCE5279-D107-49F5-B4CC-F563910F2237Q63399295-04AEA934-3BF8-4700-AB67-234937A3F3BFQ63399840-F3030BDE-B559-42A3-AB74-806B0B2BDB0CQ63570709-C3FC4246-0495-4C08-B71F-347B99917CF0Q63572702-11EED2B1-45E1-4072-8A82-F0C6EE587AAEQ63577900-DD87D31A-6EB1-424E-BE37-0AEC273F780FQ63578356-29E1E540-8619-46C6-871A-D2255F56AE27Q63578791-812F4DA0-7B1D-4056-B866-302329A7A85AQ63580352-71277F7B-F3BB-4F9F-9230-170554F51BE5Q63591632-A97F7EB4-8D74-4EF9-ACCD-67093C37495AQ63591633-7FE07F31-EBE8-440D-8EDF-C86D991651D0Q63592203-CC743AC2-3BCD-408A-AAC0-1ED3BDAEA831Q63592666-B83800F3-9843-4074-94D8-5F0398826158Q63596120-0B6BC302-FE1C-4020-AA49-632863F53003Q63613348-7CDB46DF-0192-466E-ACC1-50DDC94E6A2DQ63805424-700AB5CD-713C-4A84-B6A0-2AE0B2D82C3FQ86254578-F3E38773-4051-44B9-ACF3-DF2F5B50AF56Q87076591-AB1A95A7-1793-49EF-B4E4-C40D6CF98240Q87931585-1C5CCB6C-3861-4F74-938D-35BDDCDCC1E7
P4844
description
Legena eta tuberkulosiaren kontrako medikamentua, guztiz eraginkorra dena
@eu
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Isoniacida
@es
Isoniasied
@af
Isoniatsidi
@fi
Isoniazid
@cs
Isoniazid
@da
Isoniazid
@de
Isoniazid
@id
Isoniazid
@nb
Isoniazid
@sv
Isoniazid
@vi
type
label
Isoniacida
@es
Isoniasied
@af
Isoniatsidi
@fi
Isoniazid
@cs
Isoniazid
@da
Isoniazid
@de
Isoniazid
@id
Isoniazid
@nb
Isoniazid
@sv
Isoniazid
@vi
altLabel
4-pyridinecarbohydrazide
@en
4-吡啶甲酰肼
@zh
54-85-3
@fr
C6H7N3O
@fr
C6H7N3O1
@it
Dow-Isoniazid
@en
Hyzyd
@en
INAH
@ja
INH
@cs
INH
@en
prefLabel
Isoniacida
@es
Isoniasied
@af
Isoniatsidi
@fi
Isoniazid
@cs
Isoniazid
@da
Isoniazid
@de
Isoniazid
@id
Isoniazid
@nb
Isoniazid
@sv
Isoniazid
@vi